MedPath
NMPA Approval

Salbutamol Inhalation Aerosol

国药准字H14020757

July 16, 2021

国药准字H14020757

Drug Information

沙丁胺醇吸入气雾剂

气雾剂

混悬型 每罐200揿,每揿含沙丁胺醇0.10mg

化学药品

July 16, 2021

Company Information

Applicant Company

山西省太原市迎泽区新建南路86号

Manufacturing Company

太原市中北高新技术产业园区钢园北路65号

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

沙丁胺醇吸入气雾剂 - NMPA 批准文号 | MedPath